Galderma Pharma S.A. Company Profile

00:44 EST 23rd November 2017 | BioPortfolio

Galderma KK, the fully-owned Japanese arm of Galderma, was established in 1996. It has been marketing the topical anti-fungal product Pekiron(R) Cream 0.5% (Loceryl(R)) under a licensing agreement with Kyorin Pharmaceutical since 2002. With the introduction of Differin(R) Gel 0.1% in Japan, Galderma KK, aims to provide comprehensive scientific information to prescribers and medical institutions, with the goal of improving treatment outcomes, as well as the quality of life of Japanese acne patients.

News Articles [590 Associated News Articles listed on BioPortfolio]

Galderma secures FDA approval for Differin Gel as OTC treatment for acne

Galderma's U.S. affiliate, Galderma Laboratories received approval from the U.S. Food and Drug Administration (FDA) for Differin Gel (adapalene gel 0.1%) as an over-the-counter (OTC) treatment for acn...

Galderma Pharma S.A. Names To Oversee Prescription Business Unit

  Life Sciences Jobs   ...

Galderma Pharma S.A. Release: ???CLEAR??? (IGA 0) Rosacea Patients Experience A Delayed Time To Relapse

  Life Sciences Jobs   ...

Galderma Pharma S.A.: Combined Use Of Rosacea Therapies Ivermectin 1% Cream And Brimonidine 0.33% Gel Evaluated In MOSAIC Study

  Life Sciences Jobs   ...

Nestle to cut up to 450 jobs at Galderma research center in France

ZURICH (Reuters) - Nestle said it plans to cut up to 450 jobs at a research and development center for its skin health business Galderma in southern France, as it seeks to make the underperforming uni...

Galderma Laboratories Announces FDA Approval Of Restylane Silk As The First HA Dermal Filler Approved For Injection Via Cannula

FORT WORTH, Texas, Oct. 12, 2017 /PRNewswire/ --Galderma, a global leader focused on medical solutions in skin health, announced today it has received U.S. Food and Drug Administration (FDA) approval ...

Galderma® CareConnect Patient Savings Card Program Passes Milestone

Remarkably Simple Patient Savings Provides Increased Access and Affordability The Galderma® CareConnect patient savings program has surpassed the mark of 1,000,000 pre...

Nestle's Galderma Laboratories to Slash Up to 450 Jobs at R&D Center

PubMed Articles [24 Associated PubMed Articles listed on BioPortfolio]

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

Bioanalytical outsourcing: transitioning from Pharma to CRO.

Clinical Trials Series - Large Pharma.

AI-powered drug discovery captures pharma interest.

Arkansas execution proceeds as pharma companies lose battle to stop use of their drugs.

Clinical Trials [83 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [731 Associated Companies listed on BioPortfolio]

Galderma Pharma S.A.

Galderma KK, the fully-owned Japanese arm of Galderma, was established in 1996. It has been marketing the topical anti-fungal product Pekiron(R) Cream 0.5% (Loceryl(R)) under a licensing agreement...

Galderma, MTV

Galderma is one of the world's leading pharmaceutical companies, focusing exclusively on the research, development and marketing of dermatological products. Its expertise spans a broad spectrum of...

Galderma Laboratories

Galderma’s ambition is to be recognized as the most competent and successful innovation-based company focused exclusively on meeting the needs of dermatology patients and phy...

Galderma Laboratories, L.P.

Galderma, created in 1981 as a joint venture between Nestle and L'Oreal, is a fully-integrated specialty pharmaceutical company dedicated exclusively to the field of dermatology. The Company has a pre...

NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals is a biopharmaceutical company focusing commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of...

More Information about "Galderma Pharma S.A." on BioPortfolio

We have published hundreds of Galderma Pharma S.A. news stories on BioPortfolio along with dozens of Galderma Pharma S.A. Clinical Trials and PubMed Articles about Galderma Pharma S.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Galderma Pharma S.A. Companies in our database. You can also find out about relevant Galderma Pharma S.A. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Acne is a common skin condition that causes spots to develop on the skin, usually on the face, back and chest..  The spots can range from blackheads and whiteheads which are often mild, to inflamed pus-filled pustules and cysts, which can be severe ...

Corporate Database Quicklinks

Searches Linking to this Company Record